- Home
- CRBU vs EDF Comparison
CRBU vs EDF Comparison
Compare CRBU & EDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- EDF
- Stock Information
- Founded
- CRBU 2011
- EDF 2010
- Country
- CRBU United States
- EDF United States
- Employees
- CRBU N/A
- EDF N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- EDF Investment Managers
- Sector
- CRBU Health Care
- EDF Finance
- Exchange
- CRBU Nasdaq
- EDF Nasdaq
- Market Cap
- CRBU 165.8M
- EDF 160.2M
- IPO Year
- CRBU 2021
- EDF N/A
- Fundamental
- Price
- CRBU $1.78
- EDF $5.05
- Analyst Decision
- CRBU Strong Buy
- EDF
- Analyst Count
- CRBU 3
- EDF 0
- Target Price
- CRBU $6.67
- EDF N/A
- AVG Volume (30 Days)
- CRBU 729.3K
- EDF 160.6K
- Earning Date
- CRBU 11-05-2025
- EDF 01-01-0001
- Dividend Yield
- CRBU N/A
- EDF 13.14%
- EPS Growth
- CRBU N/A
- EDF N/A
- EPS
- CRBU N/A
- EDF N/A
- Revenue
- CRBU $9,121,000.00
- EDF N/A
- Revenue This Year
- CRBU $9.23
- EDF N/A
- Revenue Next Year
- CRBU N/A
- EDF N/A
- P/E Ratio
- CRBU N/A
- EDF N/A
- Revenue Growth
- CRBU N/A
- EDF N/A
- 52 Week Low
- CRBU $0.66
- EDF $3.51
- 52 Week High
- CRBU $3.00
- EDF $5.50
- Technical
- Relative Strength Index (RSI)
- CRBU 46.16
- EDF 44.55
- Support Level
- CRBU $1.72
- EDF $4.97
- Resistance Level
- CRBU $1.94
- EDF $5.09
- Average True Range (ATR)
- CRBU 0.11
- EDF 0.06
- MACD
- CRBU -0.01
- EDF -0.01
- Stochastic Oscillator
- CRBU 26.53
- EDF 34.78
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About EDF Virtus Stone Harbor Emerging Markets Income Fund of Beneficial Interest
Virtus Stone Harbor Emerging Markets Income Fund is a closed-end management investment company. Its investment objective is to maximize total return, which consists of income from its investments and capital appreciation. The Fund normally will invest at least 80% of its net assets (plus any borrowings for investment purposes) in emerging markets securities.